Analyst Scoreboard: 4 Ratings For GE HealthCare Techs
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for GE HealthCare Techs (NASDAQ:GEHC) over the past three months, with a recent increase in the average 12-month price target to $91.0. The company's financials show strong net margins and ROE, but challenges in ROA and high debt levels.
September 26, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
GE HealthCare Techs received mixed analyst ratings, with a new average price target of $91.0, up from $84.0. Financials show strong net margins and ROE, but challenges in ROA and high debt levels.
The mixed analyst ratings indicate uncertainty in the market's perception of GEHC. The increase in the average price target suggests some optimism, but the financials reveal both strengths (net margins, ROE) and weaknesses (ROA, debt levels). This results in a neutral short-term impact as the positive and negative factors may offset each other.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100